Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in


October 2012
Scientific News
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
30 Sep 2012 - 03 Oct 2012
Congress Center Hamburg (CCH), Am Dammtor/Marseiller Straße, 20355 Hamburg
64th Annual Meeting of the German Society for Hygiene and Microbiology (DGHM) 2012
Managing Partnerships with CROs
03 Oct 2012 - 04 Oct 2012
London, UK
Managing Partnerships with CROs
Pharma Commercial Excellence in CEE, CIS, SEE & Turkey
04 Oct 2012 - 05 Oct 2012
Budapest, Hungary
Pharma Commercial Excellence in CEE, CIS, SEE & Turkey
05 Oct 2012 - 07 Oct 2012
Rochester, MI
2nd Midwest Conference on Stem Cell Biology and Therapy
07 Oct 2012 - 09 Oct 2012
Square Brussels Meeting Centre, Brussels
BioPartnering FutureEurope
Site Feasibility and Study Start Up
17 Oct 2012 - 18 Oct 2012
London, UK
Site Feasibility and Study Start Up
World Drug Delivery & Formulation Summit Asia
17 Oct 2012 - 18 Oct 2012
Singapore, Singapore
World Drug Delivery & Formulation Summit Asia
23 Oct 2012 - 24 Oct 2012
London, UK
00S Investigations in a GMP environment
Flow Chemistry Asia - 2012
25 Oct 2012 - 26 Oct 2012
Flow Chemistry Asia - 2012
<< 1 2 >>

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos